Furthermore, to find more accurate biomarkers for identifying ESCC patients, we assessed the diagnostic utility of four genes (TP53, FAT3, MLL3, and AJUBA), mutations in which are the most recurrently detected. The gene discussed is KMT2C; the disease is esophageal squamous cell carcinoma.